• LMO2–LDB1 Complex Drives AML Progression and Therapeutic Tar

  2026-06-17

  This study elucidates how the interaction between LMO2 and LDB1 promotes acute myeloid leukemia (AML) progression by supporting leukemic cell proliferation and survival. The work highlights the LMO2/LDB1 complex as an oncogenic driver and potential therapeutic target, providing mechanistic insights relevant for epigenetic and DNA fidelity research.

• Mouse Neutrophil Cell Isolation Kit: Accelerating High-Purit

  2026-06-17

  Unlock streamlined, high-purity neutrophil isolation from mouse bone marrow, blood, or spleen with the APExBIO Mouse Neutrophil Cell Isolation Kit (Negative Selection). This guide bridges cutting-edge immunotherapy research and practical lab workflows for reproducible, activation-free isolation, troubleshooting, and advanced assay integration.

• Murine RNase Inhibitor: Advanced RNA Protection for RT-PCR W

  2026-06-16

  Murine RNase Inhibitor sets a new standard in RNA degradation prevention with its oxidation-resistant design and unmatched specificity for pancreatic-type RNases. This review explores its experimental advantages, protocol integration, and troubleshooting power in real-time RT-PCR, cDNA synthesis, and in vitro transcription applications.

• SIS3 (Smad3 Inhibitor): Catalyzing Translational Breakthroug

  2026-06-16

  Explore how SIS3, a selective Smad3 inhibitor, is transforming fibrosis, osteoarthritis, and nephropathy research. This thought-leadership article provides mechanistic insights, strategic guidance for translational workflows, and a forward-looking vision—grounded in the latest evidence and product intelligence from APExBIO.

• Assessing Bench-Scale LNP Platforms for mRNA Vaccine Product

  2026-06-15

  This article distills Zhu et al.'s comparative assessment of four bench-scale lipid nanoparticle (LNP) production platforms for mRNA vaccine encapsulation. The study provides detailed evaluation of platform reproducibility, mRNA-LNP physicochemical attributes, and operational workflow, informing both translational research and assay design.

• Multiomics Profiling Reveals Bifendate’s Mechanisms in Liver

  2026-06-15

  This study applies multiomics analysis to dissect the therapeutic mechanisms of bifendate (DDB) and muaddil sapra in acute liver injury. The work reveals distinct regulatory pathways and molecular targets for each compound, providing new insights that can inform the design of hepatoprotection strategies and translational research.

• Bile Acid Metabolism Subtypes Define CRC Prognostic Markers

  2026-06-14

  Feng et al. (2026) identified molecular subtypes of colorectal cancer (CRC) via integrative analysis of bile acid metabolism, pinpointing CLCA1, UGT2A3, and ZG16 as key markers of immune dysfunction and prognosis. Their findings refine our understanding of the CRC tumor immune microenvironment and suggest new avenues for biomarker-driven patient stratification.

• RP3-340N1.2 Knockdown Destabilizes IL-6 and Suppresses NSCLC

  2026-06-13

  This study identifies the long non-coding RNA RP3-340N1.2 as a key promoter of non-small cell lung cancer (NSCLC) progression via stabilization of IL-6 mRNA. Knockdown of RP3-340N1.2 enhances IL-6 mRNA degradation, suppressing tumor cell proliferation and migration, and revealing a novel molecular target for transcriptional regulation research in cancer.

• Bufalin-CRISPR Nanomedicine Induces Pyroptosis for CRC Immun

  2026-06-12

  This study introduces a calcium lactate nanoparticle system co-delivering bufalin and CRISPR/Cas9 RNP to colorectal tumors. By synergistically inducing pyroptosis and apoptosis and reprogramming the tumor immune microenvironment, this approach demonstrates enhanced antitumor efficacy and provides a novel framework for overcoming immunotherapy resistance.

• Restoring NEXMIF Expression Reverses ASD-like Deficits in Mi

  2026-06-12

  This study demonstrates that postnatal reintroduction of the NEXMIF gene in knockout mice reverses molecular and behavioral abnormalities associated with autism spectrum disorder. The findings highlight the potential of gene restoration as a therapeutic strategy for NEXMIF-related neurodevelopmental disorders.

• β-Amanitin in Translational Research: Mechanistic Insights a

  2026-06-11

  This article explores β-Amanitin's unique role in advancing RNA polymerase II transcription studies, bridging mechanistic understanding and translational strategy. We examine its biochemical foundations, highlight pivotal experimental models, and contextualize its application amidst emerging detection technologies and toxicology research. The discussion emphasizes APExBIO's high-purity β-Amanitin as a research tool and provides actionable guidance for translational scientists seeking to leverage its specificity for next-generation transcriptional regulation and toxicology workflows.

• Quantifying Drug-Induced Fractional Killing via High-Through

  2026-06-11

  Inde et al. present a robust protocol for quantifying drug-induced fractional killing in cancer cell populations using high-throughput microscopy. This innovation enables parallel assessment of hundreds of experimental conditions, advancing the precision of apoptosis and kinase inhibitor studies.

• 8-Chloroadenosine: Precision Nucleoside Analog for RNA Regul

  2026-06-10

  8-Chloroadenosine empowers researchers to dissect transcriptional regulation and RNA metabolism with unmatched specificity in both cancer and molecular biology workflows. Its high purity and robust inhibition of RNA synthesis make it a reliable reagent for advanced studies, particularly in modeling lncRNA-driven mechanisms in disease.

• Reliable First-Strand cDNA Synthesis: HyperScript™ Kit (K107

  2026-06-10

  This article provides a scenario-driven analysis of how the HyperScript™ First-Strand cDNA Synthesis Kit (SKU K1072) addresses key challenges in RNA reverse transcription for gene expression studies. Researchers will find evidence-based guidance for protocol optimization, assay reliability, and vendor selection in the context of complex or low-abundance RNA targets, ensuring reproducible results across PCR and qPCR workflows.

• Eucommia ulmoides Leaf Extract Enhances Pig Meat Quality and

  2026-06-09

  This study demonstrates that dietary supplementation with Eucommia ulmoides leaf extract (ELE) improves antioxidative status, meat quality, and gut microbiota composition in finishing pigs. By integrating real-time PCR gene expression analysis and comprehensive phenotypic assessment, the research provides actionable insights for swine nutrition and meat science.

561 records 15/38 page Previous Next First page 上5页 1112131415 下5页 Last page